We contribute to improving the prevention and treatment of diseases that threaten global health
The prevalence of cardiometabolic diseases has increased by more than 26% in the past 10 years
Today, more than 500 million people live with genetic and lifestyle-related cardiometabolic diseases such as diabetes, obesity and cardiovascular disease.
People do not have equal opportunities for a healthy life and treatment
Rising inequity in health is not just a problem for individuals but is also a great burden for families and society.
Infectious diseases cause millions of deaths every year and the risk of future pandemics is high
We urgently need to find global solutions for current and future infectious disease threats, as well as the growing problem of antimicrobial resistance.
Our grants
The Novo Nordisk Foundation awards grants based on applications in open competition and supports a large number of different areas within health, sustainability and life science.
Projects and initiatives we have supported
The Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI)
NIVI aims to develop new or improved vaccines for some of the deadliest respiratory diseases.
Novo Nordisk Foundation Cellerator
The initiative aims to advance the cell therapy ecosystem and enable transformative treatments.
Steno Diabetes Centers – prevention and treatment of diabetes
The aim of the Steno Diabetes Centers is to establish the optimal framework for preventing and treating diabetes and other related diseases.
Partnership for Education of Health Professionals (PEP)
With the Partnership for Education of Health Professionals (PEP), the Novo Nordisk Foundation takes a step towards reducing inequity in health by strengthening the education of nurses and other key health professionals in India, Kenya, and East Africa.
Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW)
The Foundation awarded up to DKK 2.2 billion (EUR 300 million) over a ten-year period for the centre, which is established as a partnership between three leading research institutions.
Novo Nordisk Foundation Center for Genomic Mechanisms of Disease
With a USD 47.5 million commitment over a five-year period, the Foundation supported the establishment of a centre for genomic research at the Broad Institute of MIT and Harvard in Boston (US).
Danish Diabetes and Endocrine Academy (DDEA)
The academy's purpose is to strengthen the quality of Danish diabetes and endocrine research and research education.
Pandemic Antiviral Discovery (PAD)
Together with Open Philanthropy and the Bill & Melinda Gates Foundation, the Novo Nordisk Foundation made an initial commitment of up to USD 90 million in coordinated funding towards the initiative in 2022.
Centre for Childhood Health
In 2022, the Novo Nordisk Foundation awarded a grant towards the establishment of a new centre focusing on healthy weight among children.
AMR Action Fund – global initiative to combat antimicrobial resistance
Several leading pharmaceutical companies and foundations have raised USD 1 billion to launch the AMR Action Fund. The aim is to bring two to four new antibiotics to patients by 2030.
Would you like to read more about the Novo Nordisk Foundation's 2030 strategy?
Towards 2030, we will increase our efforts towards solving urgent and global societal challenges. We have three focus areas.Impact
We continually measure the societal effect of our projects and initiatives.Health-related news
New study seeks answers on the role of diet and exercise in diabetes remission
Jacobæus Prize awarded to Finnish researcher for her groundbreaking work on fatty liver disease and diabetes
